In Bearbeitung

Bitte warten ...

Einstellungen

Einstellungen

Gehe zu Anmeldung

1. WO2006079508 - INIIZIERBARES MITTEL ZUR ZIELGERICHTETEN BEHANDLUNG VON RETINALEN GANGLIENZELLEN

Veröffentlichungsnummer WO/2006/079508
Veröffentlichungsdatum 03.08.2006
Internationales Aktenzeichen PCT/EP2006/000622
Internationales Anmeldedatum 25.01.2006
IPC
A61K 48/00 2006.01
ASektion A Täglicher Lebensbedarf
61Medizin oder Tiermedizin; Hygiene
KZubereitungen für medizinische, zahnärztliche oder kosmetische Zwecke
48Medizinische Zubereitungen, die genetisches Material enthalten, das in Zellen des lebenden Körpers eingeführt wird, um genetisch bedingte Krankheiten zu behandeln; Gentherapie
CPC
C12N 15/111
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
111General methods applicable to biologically active non-coding nucleic acids
C12N 15/1135
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
1135against oncogenes or tumor suppressor genes
C12N 2310/11
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2310Structure or type of the nucleic acid
10Type of nucleic acid
11Antisense
C12N 2310/14
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2310Structure or type of the nucleic acid
10Type of nucleic acid
14interfering N.A.
C12N 2320/32
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2320Applications; Uses
30Special therapeutic applications
32Special delivery means, e.g. tissue-specific
Anmelder
  • EBERHARD-KARLS-UNIVERSITÄT TÜBINGEN [DE]/[DE] (AllExceptUS)
  • THALER, Sebastian [DE]/[DE] (UsOnly)
  • SCHÜTTAUF, Frank [DE]/[DE] (UsOnly)
Erfinder
  • THALER, Sebastian
  • SCHÜTTAUF, Frank
Vertreter
  • FINDEISEN, Marco
Prioritätsdaten
10 2005 005 528.130.01.2005DE
Veröffentlichungssprache Deutsch (DE)
Anmeldesprache Deutsch (DE)
Designierte Staaten
Titel
(DE) INIIZIERBARES MITTEL ZUR ZIELGERICHTETEN BEHANDLUNG VON RETINALEN GANGLIENZELLEN
(EN) INJECTABLE AGENT FOR THE TARGETED TREATMENT OF RETINAL GANGLION CELLS
(FR) SUBSTANCE INJECTABLE POUR LE TRAITEMENT CIBLE DE CELLULES GANGLIONNAIRES DE LA RETINE
Zusammenfassung
(DE)
Die vorliegende Erfindung betrifft die zielgerichtete Behandlung von retinalen Ganglienzellen (RGC) .
(EN)
The invention relates to the targeted treatment of retinal ganglion cells (RGC) .
(FR)
La présente invention concerne le traitement ciblé de cellules ganglionnaires de la rétine (RGC).
Auch veröffentlicht als
Aktuellste beim Internationalen Büro vorliegende bibliographische Daten